Resource savings through effective:
Global Trade Compliance in Drug Development

In the intricate landscape of (bio)pharmaceutical development, international trade compliance emerges as a critical factor influencing the success of therapeutic products and medical devices. The collaboration with a full-service Contract Development and Manufacturing Organization (CDMO) takes center stage, offering expertise that spans the entire lifecycle of a drug development project. From addressing early-phase challenges to ensuring seamless tech transfers and meeting stringent regulatory guidelines, a reliable CDMO plays a pivotal role in navigating the complexities of global compliance measures.

The increasing global trade of pharmaceutical products underscores the need for (bio)pharmaceutical companies to be well-versed in international trade requirements. This white paper explores the impact of factors like the COVID-19 pandemic on global trade, emphasizing the importance of a robust international trade compliance program. Beyond mitigating risks of governmental investigations and penalties, a well-established compliance program becomes a strategic advantage, fostering a comprehensive supply chain and cost management for drugs and medical devices. The collaboration with a CDMO equipped with a dedicated trade compliance team becomes a decisive factor in ensuring consistent planning, accurate cost estimation, and enhanced delivery timelines for materials shipped across borders.

Download our white paper to gain insights on:

• Strategies to mitigate the risks of governmental investigations and penalties through the establishment of a robust international trade compliance program.
• The increasing importance of (bio)pharmaceutical companies being well-versed in international trade requirements and the impact of global events, such as the COVID-19 pandemic, on trade dynamics.
• The pivotal role of a full-service Contract Development and Manufacturing Organization (CDMO) in overcoming early-phase challenges and ensuring seamless tech transfers for (bio)pharmaceutical development.
• The strategic advantage offered by a well-established compliance program in fostering efficient supply chain management and cost control for drugs and medical devices.

Download the White Paper